University reform: Would-be university professors in Italy will in future have to pass a national exam before being eligible to apply for positions, according to a reform bill unveiled on 28 October. Education minister Mariastella Gelmini says the aim of the legislation is to stop universities from hiring unsuitable local candidates who are owed favours. It also relegates to short-term contracts the lowest of three positions on the academic scale, known as 'researchers' . The bill may be watered down on its passage through parliament, but Gelmini hopes it will be in operation by next March.
• BUSINESS Changing focus: Drug maker GlaxoSmithKline (GSK) says it has made significant progress in transforming itself from a "white pill/Western market" company into a business focused more on emerging markets and consumer health products. Fewer than 30% of GSK's third-quarter 2009 sales, reported on 28 October, came from traditional pill sales in the developed world, noted Andrew Witty, GSK's chief executive; that proportion was 38% when Witty started at the company in May 2008. GSK predicted that its H1N1 flu products would provide 'significant sales' towards the end of the year. Novartis and Sanofi-Aventis made similar predictions for their flu drugs.
Biosimilars competition:
Legislation unveiled by the US House of Representatives last week as part of a massive US health-reform bill grants makers 
CLIMATE FUNDING CREEPS CLOSER
Warming up for climate negotiations in Barcelona this week (see our blog at go.nature.com/TSZq6t), European Union leaders agreed at a summit in Brussels on 29-30 October that the 27-nation bloc would pay its "fair share" of aid to help developing countries cope with and fight climate change, although the amount was not specified. The meeting estimated that, in total, roughly €100 billion (US$148 billion) a year by 2020 would be needed, of which €22 billion to €50 billion a year would come from direct government support. "All countries, except the least developed, should contribute to international public financing," a post-meeting statement said.
of brand-name biological drugs 12 years of market exclusivity before they face competition from manufacturers of their generic equivalents, called biosimilars. A Senate version of the bill also guarantees brandname drug makers 12 years of competition-free market access -a period that the Generic Pharmaceutical Association in Arlington, Virginia, called "unwarranted and excessive". 
QUANTUM-DOT PROMISE

NEWS MAKER
David Nutt
The UK government sacked Nutt, the chair of its independent Advisory Council on the Misuse of Drugs, after he reiterated his views on the relative safety of various drugs. See Editorial, page 11, and go.nature.com/ WZ5c16 for more.
UNIV. BRISTOL
Antarctica drilling: Russia has postponed for another year its plans to drill into Antarctica's sub-glacial Lake Vostok (Nature, 454, 258-259; 2008) . Entry into the uniquely pristine lake, 3,750 metres below the Antarctic ice
• RESEARCH
Water satellite: The European Space Agency successfully launched a satellite on 2 November that will map changes in Earth's soil moisture and oceanic salt levels. The Soil Moisture and Ocean Salinity (SMOS) satellite measures microwave emissions at a particular frequency and will produce global soil-moisture maps with a spatial resolution of about 50 kilometres. See go.nature.com/DiHh2o for more.
Rocket test:
NASA successfully test-launched its prototype Ares 1-X rocket last week, although a parachute failure meant that the discarded firststage booster smacked into the ocean harder than planned, collecting a sizable dent. Ares I may replace the shuttle as the main means of getting astronauts to and from space -if its development is not cancelled
• FUNDING Stem-cell grants: The California Institute for Regenerative Medicine in San Francisco has awarded US$230 million to 14 research teams, with the intention of helping to move stem-cell therapies into the clinic within four years. The grants, which coordinate basic and clinical researchers, target a range of diseases, including brain cancer, stroke, heart attack, macular degeneration and sickle-cell anaemia. See page 22 for more. biotechnology, drugs, new energy, conservation and environmental protection.
Smart grid:
The US Department of Energy bolstered efforts to establish a 'smart' electric grid by announcing on 27 October US$3.4 billion in grants for various grid modernization projects, as well as sensors and meters intended to manage electricity consumption. The government grants will leverage an additional $4.7 billion in private money, pushing the total investment above $8 billion. 
